newsfilter
← Latest News
Business Wire·

Intersect ENT Reports First Quarter 2021 Financial Results

— Increases 2021 Revenue Guidance to $117 Million to $121 Million — Intersect ENT, Inc. (NASDAQ:XENT), a global ear, nose and throat ("ENT") medical technology leader dedicated to transforming patient care, today reported financial results for th